Authors: Bektic, J Lell, CP Fuchs, A Stoiber, H Speth, C Lass-Florl, C Borg-von Zepelin, M Dierich, MP Wurzner, R

Citation: J. Bektic et al., HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro, FEMS IM MED, 31(1), 2001, pp. 65-71

Authors: Zaugg, C Borg-von Zepelin, M Reichard, U Sanglard, D Monod, M

Citation: C. Zaugg et al., Secreted aspartic proteinase family of Candida tropicalis, INFEC IMMUN, 69(1), 2001, pp. 405-412

Authors: Monod, M Borg-von Zepelin, M Telenti, A Sanglard, D

Citation: M. Monod et al., The inhibition of Candida-albicans-secreted aspartic proteases by three different HIV protease inhibitors, DERMATOLOGY, 198(4), 1999, pp. 412-414

Authors: Gruber, A Speth, C Lukasser-Vogl, E Zangerle, R Borg-von Zepelin, M Dierich, MP Wurzner, R

Citation: A. Gruber et al., Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro, IMMUNOPHARM, 41(3), 1999, pp. 227-234

Authors: Borg-von Zepelin, M Meyer, I Thomssen, R Wurzner, R Sanglard, D Telenti, A Monod, M

Citation: M. Borg-von Zepelin et al., HIV-protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases, J INVES DER, 113(5), 1999, pp. 747-751

Authors: Schaller, M Hube, B Ollert, MW Schafer, W Borg-von Zepelin, M Thoma-Greber, E Korting, HC

Citation: M. Schaller et al., In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients, J INVES DER, 112(3), 1999, pp. 383-386